Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)
| CAPS Rating |
|
|---|---|
| Open | $14.88 |
| Previous Close | $14.96 |
| Daily Range | $14.42 - $14.97 |
| 52-Week Range | $5.52 - $15.98 |
| Market Cap | $1.94B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 3,330,455 |
| Average Daily Volume | 0 |
ARIA
VS S&P 500 (SPY)
How do you think ARIA will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ARIA Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ARIA News and Commentary
- Buy, Sell, or Hold: Ariad Pharmaceuticals – The Motley Fool
- What's Going on With These Biotech Stocks? – The Motley Fool
- This Just In: More Upgrades and Downgrades – The Motley Fool
- The Magic Formula for Biotech – The Motley Fool
- 5 Stocks That More Than Doubled in 2011 – The Motley Fool
- 2 Positive Signs for Ariad Pharmaceuticals – The Motley Fool
- ARIAD's Prolific 2011 – The Motley Fool
- Ariad Pharmaceuticals 21.5 Million-Share Offering Priced At Wednesday Close – SmartMoney
- 2 Positive Signs for Eli Lilly – The Motley Fool
- The Race to the $1,000 Genome – The Motley Fool
- The Best ETF for 2012: SPDR S&P Biotech – The Motley Fool
- Top Ten Undervalued Stocks With Large Cash Cushions – NASDAQ
- Top 10 Undervalued Stocks With Large Cash Cushions – The Motley Fool
- A Sell-the-News Buying Opportunity – The Motley Fool
- Ariad Pharmaceuticals Shares Plunged: What You Need to Know – The Motley Fool
- Bash My Stock: Ariad Pharmaceuticals – The Motley Fool
- Make Money in Strong Pharma Stocks the Easy Way – The Motley Fool
- Stocks Rebound; Euro Concerns Ease While New Home Sales, Gold Slip – NASDAQ
- Mid-Day Update: Stocks Advance Amid Easing Concern Over Europe's Debt Picture; Gold Slumps – NASDAQ
- 2 Positive Signs for Ariad Pharmaceuticals – The Motley Fool
RSS Headlines
Fool UK
